PHAS
BlackRock’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-665,563
| Closed | -$116K | – | 5849 |
|
|
2022
Q3 | $116K | Sell |
665,563
-18,641
| -3% | -$3.25K | ﹤0.01% | 5046 |
|
|
2022
Q2 | $411K | Buy |
684,204
+2,713
| +0.4% | +$1.63K | ﹤0.01% | 4744 |
|
|
2022
Q1 | $899K | Sell |
681,491
-3,906
| -0.6% | -$5.15K | ﹤0.01% | 4613 |
|
|
2021
Q4 | $1.79M | Buy |
685,397
+166,038
| +32% | +$433K | ﹤0.01% | 4379 |
|
|
2021
Q3 | $1.62M | Buy |
519,359
+32,335
| +7% | +$101K | ﹤0.01% | 4340 |
|
|
2021
Q2 | $1.81M | Sell |
487,024
-732,101
| -60% | -$2.72M | ﹤0.01% | 4248 |
|
|
2021
Q1 | $4.22M | Buy |
1,219,125
+25,518
| +2% | +$88.3K | ﹤0.01% | 3952 |
|
|
2020
Q4 | $4.01M | Buy |
1,193,607
+58,668
| +5% | +$197K | ﹤0.01% | 3722 |
|
|
2020
Q3 | $3.98M | Buy |
1,134,939
+52,770
| +5% | +$185K | ﹤0.01% | 3572 |
|
|
2020
Q2 | $4.98M | Buy |
1,082,169
+92,379
| +9% | +$425K | ﹤0.01% | 3452 |
|
|
2020
Q1 | $3.28M | Sell |
989,790
-9,918
| -1% | -$32.8K | ﹤0.01% | 3435 |
|
|
2019
Q4 | $6.11M | Buy |
999,708
+79,666
| +9% | +$487K | ﹤0.01% | 3396 |
|
|
2019
Q3 | $3.84M | Buy |
920,042
+24,615
| +3% | +$103K | ﹤0.01% | 3515 |
|
|
2019
Q2 | $11.7M | Buy |
895,427
+850,166
| +1,878% | +$11.2M | ﹤0.01% | 3131 |
|
|
2019
Q1 | $430K | Buy |
45,261
+19,952
| +79% | +$190K | ﹤0.01% | 4071 |
|
|
2018
Q4 | $79K | Buy |
+25,309
| New | +$79K | ﹤0.01% | 4352 |
|